Science. Business. Everything between.

Overview of the Japanese Bio startup market

What images come to mind when you think about Japan? Sushi? Cartoons? Manufacturing? Startups are probably not in that list and for a good reason. As the table below shows, entrepreneurial intentions are quite low in Japan. Many young people try to get jobs in companies such as Toyota and Sony and do not consider entrepreneurship as a career choice.

 Perception of entrepreneurship in different countries:

Country Entrepreneurial intentions Entrepreneurship as a good career choice
Japan

2

30

Republic of Korea

13

59

UK

10

50

US

13

(N/A)

Reflecting the trend above [1], the investment in Japanese startup companies remains far behind the United States.

Country

Investment(M£)

Investment(Local currency]

Japan [2]

8,510

1,240,000,000,000(JPY)

U.K. [3]

6,544

6,544,000,000(GBP)

U.S. [4]

18,274

28,700,000,000(USD)

Republic of Korea [5]

731

1,260,800,000,000(won)

However, even in this environment, the number of Japanese bio startup companies is gradually growing. The following chart shows the cumulative number of bio startup companies in Japan between 1992 and 2011. After strong growth in the 90′s, the number of bio startup companies remained flat from 2005. In 2011, six new bio-related companies were founded. [6]

 

Blue shows the total number of bio startup companies. Red shows the number of bio startups relating to medicine.
The trends of bio-startup companies.
Blue shows the total number of bio startup companies. Red shows the number of bio startups relating to medicine. [7]

 

Trend of IPOs

In 2000, the Japanese government conducted some projects to promote the incubation of startup companies. As a result, 22 out of 538 bio startup companies successfully completed their initial public offering. Five of those IPOs were launched in 2011 [8]. The nature of businesses launching IPOs also changed over time. In 2000, most businesses undertaking IPOs were related to supporting research business which provides devices or services for experiments. Between 2009 and 2011, most IPOs were launched by businesses related to drug development [9]. The change from research to drug development was due to the growth of Japanese bio industry.

Distribution of bio startup companies

The distribution of headquarter locations of bio startup companies (January 2012) The colour shows the number of headquarters. Light blue means from 1 to 4, the darkest red means 30+.
The distribution of headquarter locations of bio startup companies (January 2012).
The colour shows the number of headquarters.
Light blue means from 1 to 4, the darkest red means 30+ [10]

 

The three most popular areas are Tokyo, Hokkaido, and Kansai. At first, Tokyo, being the capital of Japan has many research oriented universities like Tokyo University. In addition, financial institutions such as venture capitals have offices in Tokyo area. Convenience for business is the main reason for the concentration of bio startup companies.

The northern island, Hokkaido is home to the Hokkaido Bio Industrial Cluster. The Hokkaido Bureau of Economy, Trade and Industry (METI Hokkaido) has been actively supporting bio-startup companies as part of an overall revitalisation of the region. Programs such as the “Hokkaido Super Cluster Promotion Project” bring together private industry, national universities and regional governments to share resources and expertise. METI Hokkaido also has specific programs to help innovation in the biotechnology industry.

In the Kansai area, the Osaka prefectural government has been promoting the growth of a bio cluster since 2000. As the result, Osaka was introduced as “one of the world’s most successful biomedical clusters” in the magazine, Nature. As early as 1660, this area has been manufacturing chemicals used in medicine and currently hosts research institutions such as Osaka University and National Cerebral and Cardiovascular Centre.

Conclusion

In Japan, the bio startup community is not big yet, but it is steadily growing. I believe the Japanese bio startup community is key to the revitalisation of the Japanese economy. To promote the growth of bio industry, investment for bio startup companies and hands-on support from management or commercialisation perspective are necessary.

[1] Babson college, Global Entrepreneurs Monitor 2012 Global Report (accessed on 2nd Feb 2013)

[2] Venture Enterprise Center  (accessed on 2nd Feb 2013)

[3] British Private Equity & Venture Capital Association, BVCA Private Equity and Venture Capital Report on Investment Activity 2011.  (accessed on 2nd Feb 2013)

[4] Venture Enterprise Center

[5] KVCA statistics (accessed on 14th January 2013)

[6]Japan Bioindustry Association (accessed on 2nd Feb 2013)

[7]Japan Bioindustry Association (accessed on 2nd Feb 2013)

[8] Kiyokazu Yamazaki, Capital Market Research Institute No.318, 2012

[9] Kiyokazu Yamazaki, Capital Market Research Institute No.318, 2012

[10]Japan Bioindustry Association (accessed on 2nd Feb 2013)

This post was written by:

Miho Nakamura Miho Nakamura View author bio

Search OBR

Browse by category

Next Event

View all events
Tuesday, 22nd January 2013 @ 6:30pm

Cambridge OneStart Idea Competition Launch

Cambridge Judge Business School, 40 Trumpington Street, Cambridge CB2, UK

Consulting

Innovative Business Consulting

OBR-Consulting is a unique platform to meet the growing need for consultancy at the intersection of science, business and entrepreneurship.

Learn more

Contribute to the OBR community - subscribe today for free

Copyright © 2013 Oxbridge Biotech Roundtable - All Rights Reserved

Web Design by Platførm